These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 8718928

  • 1. Skeletal muscle growth of oMTla-oGH transgenic mice.
    Sharma A, Lee YB, Murray JD, Oberbauer AM.
    Growth Dev Aging; 1996; 60(1):31-41. PubMed ID: 8718928
    [Abstract] [Full Text] [Related]

  • 2. Dependence of increased linear bone growth on age at oMT1a-oGH transgene expression in mice.
    Oberbauer AM, Pomp D, Murray JD.
    Growth Dev Aging; 1994; 58(2):83-93. PubMed ID: 7928023
    [Abstract] [Full Text] [Related]

  • 3. Effects of pre and antenatal elevated and chronic oMt1a-oGH transgene expression on adipose deposition and linear bone growth in mice.
    Oberbauer AM, Cruickshank J, Thomas A, Stumbaugh A, Evans KD, Murray JD, Egan AR.
    Growth Dev Aging; 2001; 65(1):3-13. PubMed ID: 11548870
    [Abstract] [Full Text] [Related]

  • 4. Consequences of limited exposure to elevated growth hormone in the mature oMt1a-oGH transgenic mouse.
    Oberbauer AM, Murray JD.
    Growth Dev Aging; 1998; 62(3):87-93. PubMed ID: 9894170
    [Abstract] [Full Text] [Related]

  • 5. The response of transgenic mice to beta-adrenergic agonist administration is different from that of normal mice.
    Sharma AK, Lee YB, Murray JD.
    J Anim Sci; 1997 Aug; 75(8):2092-9. PubMed ID: 9263056
    [Abstract] [Full Text] [Related]

  • 6. Dissociation of body growth and adipose deposition effects of growth hormone in oMt1a-oGH transgenic mice.
    Oberbauer AM, Stiglich C, Murray JD, Keen CL, Fong DL, Smith LB, Cushwa S.
    Growth Dev Aging; 2004 Aug; 68(1):33-45. PubMed ID: 15307663
    [Abstract] [Full Text] [Related]

  • 7. Body composition of inactivated growth hormone (oMt1a-oGH) transgenic mice: generation of an obese phenotype.
    Oberbauer AM, Stern JS, Johnson PR, Horwitz BA, German JB, Phinney SD, Beermann DH, Pomp D, Murray JD.
    Growth Dev Aging; 1997 Aug; 61(3-4):169-79. PubMed ID: 9546108
    [Abstract] [Full Text] [Related]

  • 8. Effects of zinc ion concentration on growth, fat content and reproduction in oMT1a-oGH transgenic mice.
    Eisen EJ, Peterson CB, Parker IJ, Murray JD.
    Growth Dev Aging; 1998 Aug; 62(4):173-86. PubMed ID: 10219707
    [Abstract] [Full Text] [Related]

  • 9. Growth characteristics of metallothionein-human growth hormone transgenic mice as compared to mice selected for high eight-week body weight and unselected controls. II. Skeleton.
    Wolf E, Rapp K, Wanke R, Hermanns W, Pirchner F, von Butler-Wemken I, Brem G.
    Growth Dev Aging; 1991 Aug; 55(4):237-48. PubMed ID: 1813442
    [Abstract] [Full Text] [Related]

  • 10. Development of obesity following inactivation of a growth hormone transgene in mice.
    Pomp D, Oberbauer AM, Murray JD.
    Transgenic Res; 1996 Jan; 5(1):13-23. PubMed ID: 8589737
    [Abstract] [Full Text] [Related]

  • 11. Obesity and elevated plasma leptin concentration in oMT1A-o growth hormone transgenic mice.
    Oberbauer AM, Runstadler JA, Murray JD, Havel PJ.
    Obes Res; 2001 Jan; 9(1):51-8. PubMed ID: 11346667
    [Abstract] [Full Text] [Related]

  • 12. Growth characteristics of metallothionein-human growth hormone transgenic mice as compared to mice selected for high eight-week body weight and unselected controls. I. Body weight gain and external body dimensions.
    Wolf E, Wanke R, Hermanns W, Brem G, Pirchner F, von Butler-Wemken I.
    Growth Dev Aging; 1991 Jan; 55(4):225-35. PubMed ID: 1813441
    [Abstract] [Full Text] [Related]

  • 13. Regulation of insulin-like growth factor-I and binding protein-3 expression in oMtla-oGH transgenic mice.
    Chow JC, Murray JD, Pomp D, Baldwin RL, Calvert CC, Oberbauer AM.
    Transgenic Res; 1994 Mar; 3(2):127-33. PubMed ID: 7514921
    [Abstract] [Full Text] [Related]

  • 14. Increased fat mass, decreased myofiber size, and a shift to glycolytic muscle metabolism in adolescent male transgenic mice overexpressing IGFBP-2.
    Rehfeldt C, Renne U, Sawitzky M, Binder G, Hoeflich A.
    Am J Physiol Endocrinol Metab; 2010 Aug; 299(2):E287-98. PubMed ID: 20501873
    [Abstract] [Full Text] [Related]

  • 15. Expression of metallothionein-human growth hormone fusion genes in transgenic mice results in disproportionate skeletal gigantism.
    Wolf E, Rapp K, Brem G.
    Growth Dev Aging; 1991 Aug; 55(2):117-27. PubMed ID: 1938045
    [Abstract] [Full Text] [Related]

  • 16. Myogenesis and muscle metabolism in juvenile Atlantic salmon (Salmo salar) made transgenic for growth hormone.
    Levesque HM, Shears MA, Fletcher GL, Moon TW.
    J Exp Biol; 2008 Jan; 211(Pt 1):128-37. PubMed ID: 18083741
    [Abstract] [Full Text] [Related]

  • 17. Leptin modulates fertility under the influence of elevated growth hormone as modeled in oMt1a-oGH transgenic mice.
    Thomas AD, Murray JD, Oberbauer AM.
    J Endocrinol; 2004 Sep; 182(3):421-32. PubMed ID: 15350184
    [Abstract] [Full Text] [Related]

  • 18. Transfer of an ovine metallothionein-ovine growth hormone fusion gene into swine.
    Pursel VG, Wall RJ, Solomon MB, Bolt DJ, Murray JE, Ward KA.
    J Anim Sci; 1997 Aug; 75(8):2208-14. PubMed ID: 9263070
    [Abstract] [Full Text] [Related]

  • 19. Regulation of fat and muscle development by transforming growth factor alpha in transgenic mice and in cultured cells.
    Luetteke NC, Lee DC, Palmiter RD, Brinster RL, Sandgren EP.
    Cell Growth Differ; 1993 Mar; 4(3):203-13. PubMed ID: 8466858
    [Abstract] [Full Text] [Related]

  • 20. Growth hormone modulates the degradative capacity of muscle nucleases but not of cathepsin D in post-weaning mice.
    López-Oliva ME, Agis-Torres A, Márquez E, Muñoz-Martínez E.
    Comp Biochem Physiol A Mol Integr Physiol; 2007 Sep; 148(1):159-67. PubMed ID: 17498991
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.